Table II. Glycosylation sites, (glyco)peptide sequences, non-glycosylated glycopeptide masses (Da), N-glycan occupancies, degrees of fucosylation, degrees of sialylation and distribution of branching as well as the relative accessibility to the individual glycosylation sites. These results are based on glycopeptide profiling.
Glycosylation site (residue) | Glycopeptide (trypsin + Asp-N generated) | Non-glycosylated glycopeptide mass | N-Glycan occupancy | Degree of fucosylation | Degree of sialylation (mol NeuAc/mol N-Glycan) | Branching distribution (B:T:Te:P)b | Relative accessibility to sitec |
---|---|---|---|---|---|---|---|
1 (Asn9) | Met1-Arg15 | 1755.76 Da | 96.7% | 17.2% | 100% (2.45) | 48:50:2:0 | N/A |
2 (Asn74) | Ala65-Arg78 | 1558.85 Da | 99.5% | 13.7% | 100% (2.86) | 21:35:41:3 | 1.00 |
3 (Asn154) | Asn154-Lys155 | 260.15 Da | 89.0%a | 14.1%a | 100% (2.18)a | 76:21:2:0a | 0.80 |
4 (Asn238) | Asp223-Pro246 | 2740.32 Da | 70.5% | 0.0% | 100% (2.10) | 79:21:0:0 | 0.28 |
5 (Asn308) | Asp301-Arg311 | 1311.62 Da | 96.3% | 4.7% | 100% (2.26) | 71:29:0:0 | 0.23 |
6 (Asn347) | Asp337-Arg356 | 2056.15 Da | 84.7% | 34.9% | 100% (2.89) | 18:71:9:2 | N/A |
Global (CBG) | 5.4 mol glycan/mol CBG | 0.76 mol Fuc/mol CBG | 13.3 mol NeuAc/mol CBG | 51:38:10:1 |
a The quantitation and occupancy of N-glycans from this glycosylation site were determined from a separate digest exclusively with endoproteinase Asp-N generating the (glyco)peptide Asp140-Val161 (2506.33 Da).
b It was not possible to determine whether N-glycans with five LacNAc units attached to the core were a mix of penta-antennary and tetra-antennary structures with one LacNAc extension.
c See ‘Experimental Procedures’ and supplementary Fig. S4 for information on the relative accessibility to the individual glycosylation sites.